UCB SA (EBR:UCB)
Belgium · Delayed Price · Currency is EUR 184.50
0.00 (0.00%)
Aug 8, 2025, 5:35 PM CET
UCB SA Market Cap
UCB SA has a market cap or net worth of €35.05 billion as of August 8, 2025. Its market cap has increased by 19.48% in one year.
Market Cap
35.05B
Enterprise Value
36.32B
Revenue
6.85B
Ranking
n/a
PE Ratio
26.87
Stock Price
€184.50
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 890.67M to 35.05B, an increase of 3,835.74%. That is a compound annual growth rate of 12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 35.05B | -3.87% |
| Dec 31, 2024 | 36.46B | 143.60% |
| Dec 29, 2023 | 14.97B | 7.12% |
| Dec 30, 2022 | 13.97B | -26.25% |
| Dec 31, 2021 | 18.95B | 18.70% |
| Dec 31, 2020 | 15.96B | 19.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 34.79B |
| Financière de Tubize | 6.70B |
| Fagron NV | 1.51B |
| Ion Beam Applications | 333.64M |
| Nyxoah | 241.83M |
| Onward Medical | 187.29M |
| Hyloris Pharmaceuticals | 181.44M |
| Sequana Medical NV | 71.87M |